TG Therapeutics, Inc. (TGTX)
39.52
-1.27
(-3.11%)
USD |
NASDAQ |
May 15, 16:00
39.45
-0.07
(-0.18%)
After-Hours: 20:00
TG Therapeutics Total Liabilities (Quarterly) : 945.71M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Krystal Biotech, Inc. | 120.24M |
| Precision BioSciences, Inc. | 67.79M |
| AnaptysBio, Inc. | 316.94M |
| Catalyst Pharmaceuticals, Inc. | 134.91M |
| Geron Corp. | 305.01M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.529B |
| Shareholders Equity (Quarterly) | 583.13M |
| Debt to Equity Ratio | 1.292 |
| Current Ratio | 5.809 |
| Net Debt Paydown Yield | -1.97% |